Using the available bovine TdT antigen, Bollum provided an alternative method for developing an antibody for human diagnostic reagents, and detected new forms of TdT in human lymphoblastic leukemia and lymphoma [19,107]. Here, DNTT is linked to acute lymphoblastic leukemia.